APOH and myocardial infarction: In patients with type 2 diabetes or myocardial infarction, plasma β2GP I and oxidized low-density lipoprotein (oxLDL)/β2GP I complex levels are significantly increased; these are predicted adverse consequences of cardiovascular events [5].